Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Jiahui Zhang, Jingyi Fan, Mariusz Skwarczynski, Rachel J Stephenson, Istvan Toth & Waleed M Hussein. (2022) Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances. International Journal of Nanomedicine 17, pages 869-900.
Read now
Read now
Yan Zhao, Huan Wang, Yang Yang, Wendan Jia, Tong Su, Yuxin Che, Yixin Feng, Xuemei Yuan & Xuelian Wang. (2020) Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice. International Journal of Nanomedicine 15, pages 9571-9586.
Read now
Read now
Heather L. Torrey, Valarmathy Kaliaperumal, Yogesh Bramhecha, Genevieve M. Weir, Ann R. Falsey, Edward E. Walsh, Joanne M. Langley, Bert Schepens, Xavier Saelens & Marianne M. Stanford. (2020) Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein. Human Vaccines & Immunotherapeutics 16:9, pages 2007-2017.
Read now
Read now
Marie-Laurence Tremblay, Zoe O’Brien-Moran, James A. Rioux, Andrea Nuschke, Christa Davis, W. Martin Kast, Genevieve Weir, Marianne Stanford & Kimberly D. Brewer. (2020) Quantitative MRI cell tracking of immune cell recruitment to tumors and draining lymph nodes in response to anti-PD-1 and a DPX-based immunotherapy. OncoImmunology 9:1.
Read now
Read now
Ava Vila-Leahey, Alecia MacKay, Liliana Portales-Cervantes, Genevieve M. Weir, Alexandra Merkx-Jacques & Marianne M. Stanford. (2020) Generation of highly activated, antigen-specific tumor-infiltrating CD8+ T cells induced by a novel T cell-targeted immunotherapy. OncoImmunology 9:1.
Read now
Read now
Laura Escribà-Garcia, Carmen Alvarez-Fernández, Ana Carolina Caballero, Robert Schaub, Jorge Sierra & Javier Briones. (2019) The novel agonistic iNKT-cell antibody NKT14m induces a therapeutic antitumor response against B-cell lymphoma. OncoImmunology 8:2.
Read now
Read now
Troels Holz Borch, Lotte Engell-Noerregaard, Trine Zeeberg Iversen, Eva Ellebaek, Özcan Met, Morten Hansen, Mads Hald Andersen, Per thor Straten & Inge Marie Svane. (2016) mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma. OncoImmunology 5:9.
Read now
Read now
Jonathan Pol, Aitziber Buqué, Fernando Aranda, Norma Bloy, Isabelle Cremer, Alexander Eggermont, Philippe Erbs, Jitka Fucikova, Jérôme Galon, Jean-Marc Limacher, Xavier Preville, Catherine Sautès-Fridman, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Oncolytic viruses and cancer therapy. OncoImmunology 5:2.
Read now
Read now
Neil L Berinstein, Mohan Karkada, Amit M Oza, Kunle Odunsi, Jeannine A Villella, John J Nemunaitis, Michael A Morse, Tanja Pejovic, James Bentley, Marc Buyse, Rita Nigam, Genevieve M Weir, Lisa D MacDonald, Tara Quinton, Rajkannan Rajagopalan, Kendall Sharp, Andrea Penwell, Leeladhar Sammatur, Tomasz Burzykowski, Marianne M Stanford & Marc Mansour. (2015) Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients. OncoImmunology 4:8.
Read now
Read now
Articles from other publishers (21)
Ana C. Veneziani, Eduardo Gonzalez-Ochoa, Husam Alqaisi, Ainhoa Madariaga, Gita Bhat, Marjan Rouzbahman, Suku Sneha & Amit M. Oza. (2023) Heterogeneity and treatment landscape of ovarian carcinoma. Nature Reviews Clinical Oncology 20:12, pages 820-842.
Crossref
Crossref
Zhen Zhang, Jiaqian Huang, Yuhong Xu & Huiyan Luo. (2023) Chemoimmunotherapy for esophageal squamous cell carcinoma—Summary and discussion of recent clinical trials. MedComm – Future Medicine 2:3.
Crossref
Crossref
Maria Tagliamonte & Gennaro Ciliberto. 2022. Cancer Vaccines as Immunotherapy of Cancer. Cancer Vaccines as Immunotherapy of Cancer
137
154
.
Brennan S. Dirk, Genevieve Weir, Tara Quinton, Olga Hrytsenko & Marianne M. Stanford. (2021) Combination of a T cell activating therapy and anti-phosphatidylserine enhances anti-tumour immune responses in a HPV16 E7-expressing C3 tumour model. Scientific Reports 11:1.
Crossref
Crossref
Xiran He, Yang Du, Zhijie Wang, Xin Wang, Jianchun Duan, Rui Wan, Jiachen Xu, Pei Zhang, Di Wang, Yanhua Tian, Jiefei Han, Kailun Fei, Hua Bai, Jie Tian & Jie Wang. (2020) Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma. Journal for ImmunoTherapy of Cancer 8:2, pages e000807.
Crossref
Crossref
Lei Bao, Changfu Hao, Juan Wang, Di Wang, Youliang Zhao, Yiping Li & Wu Yao. (2020) High-Dose Cyclophosphamide Administration Orchestrates Phenotypic and Functional Alterations of Immature Dendritic Cells and Regulates Th Cell Polarization. Frontiers in Pharmacology 11.
Crossref
Crossref
Istvan Toth, Mattaka Khongkow, Tzu-yu Liu, Stacey Bartlett, Waleed M Hussein, Reshma Nevagi, Zhogfan Jia, Michael J Monteiro, James Wells, Uracha Rungsardthong Ruktanonchai & Mariusz Skwarczynski. (2018) Liposomal formulation of polyacrylate-peptide conjugate as a new vaccine candidate against cervical cancer. Precision Nanomedicine 1:3, pages 183-193.
Crossref
Crossref
Kimberly D. Brewer, Genevieve M. Weir, Iulia Dude, Christa Davis, Cathryn Parsons, Andrea Penwell, Rajkannan Rajagopalan, Leeladhar Sammatur, Chris V. Bowen & Marianne M. Stanford. (2018) Unique depot formed by an oil based vaccine facilitates active antigen uptake and provides effective tumour control. Journal of Biomedical Science 25:1.
Crossref
Crossref
Chunping Ao & Kang Zeng. (2018) The role of regulatory T cells in pathogenesis and therapy of human papillomavirus-related diseases, especially in cancer. Infection, Genetics and Evolution 65, pages 406-413.
Crossref
Crossref
Lien Lybaert, Karim Vermaelen, Bruno G. De Geest & Lutz Nuhn. (2018) Immunoengineering through cancer vaccines – A personalized and multi-step vaccine approach towards precise cancer immunity. Journal of Controlled Release 289, pages 125-145.
Crossref
Crossref
Marie-Laurence Tremblay, Christa Davis, Chris V. Bowen, Olivia Stanley, Cathryn Parsons, Genevieve Weir, Mohan Karkada, Marianne M. Stanford & Kimberly D. Brewer. (2018) Using MRI cell tracking to monitor immune cell recruitment in response to a peptide-based cancer vaccine. Magnetic Resonance in Medicine 80:1, pages 304-316.
Crossref
Crossref
Yu-Jen Chen, Tung-Hu Tsai, Li-Ying Wang & Chen-Hsi Hsieh. (2017) Local Radiotherapy Affects Drug Pharmacokinetics—Exploration of a Neglected but Significant Uncertainty of Cancer Therapy. Technology in Cancer Research & Treatment 16:6, pages 705-716.
Crossref
Crossref
Simon Gebremeskel, Lynnea Lobert, Kaitlyn Tanner, Brynn Walker, Tora Oliphant, Livia E. Clarke, Graham Dellaire & Brent Johnston. (2017) Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer. Cancer Immunology Research 5:12, pages 1086-1097.
Crossref
Crossref
Zachary Benson, Saeed H. Manjili, Mehran Habibi, Georgi Guruli, Amir A. Toor, Kyle K. Payne & Masoud H. Manjili. (2017) Conditioning neoadjuvant therapies for improved immunotherapy of cancer. Biochemical Pharmacology 145, pages 12-17.
Crossref
Crossref
Yu-Li Chen, Ming-Cheng Chang & Wen-Fang Cheng. (2017) Metronomic chemotherapy and immunotherapy in cancer treatment. Cancer Letters 400, pages 282-292.
Crossref
Crossref
Genevieve M. Weir, Olga Hrytsenko, Tara Quinton, Neil L. Berinstein, Marianne M. Stanford & Marc Mansour. (2016) Anti-PD-1 increases the clonality and activity of tumor infiltrating antigen specific T cells induced by a potent immune therapy consisting of vaccine and metronomic cyclophosphamide. Journal for ImmunoTherapy of Cancer 4:1.
Crossref
Crossref
Guido Bocci & Robert S. Kerbel. (2016) Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect. Nature Reviews Clinical Oncology 13:11, pages 659-673.
Crossref
Crossref
Kimberly D. Brewer, Drew R. DeBay, Iulia Dude, Christa Davis, Kerry Lake, Cathryn Parsons, Rajkannan Rajagopalan, Genevieve Weir, Marianne M. Stanford, Marc Mansour & Chris V. Bowen. (2016) Using lymph node swelling as a potential biomarker for successful vaccination. Oncotarget 7:24, pages 35655-35669.
Crossref
Crossref
Rasha Abu Eid, Ghazaleh Shoja E. Razavi, Mikayel Mkrtichyan, John Janik & Samir N. Khleif. (2016) Old-School Chemotherapy in Immunotherapeutic Combination in Cancer, A Low-cost Drug Repurposed. Cancer Immunology Research 4:5, pages 377-382.
Crossref
Crossref
Maria Tagliamonte, Annacarmen Petrizzo, Maria Lina Tornesello, Gennaro Ciliberto, Franco M Buonaguro & Luigi Buonaguro. (2016) Combinatorial immunotherapy strategies for hepatocellular carcinoma. Current Opinion in Immunology 39, pages 103-113.
Crossref
Crossref
Drew R DeBay, Kimberly D Brewer, Sarah A LeBlanc, Genevieve M Weir, Marianne M Stanford, Marc Mansour & Chris V Bowen. (2015) Using MRI to evaluate and predict therapeutic success from depot-based cancer vaccines. Molecular Therapy - Methods & Clinical Development 2, pages 15048.
Crossref
Crossref